Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,537 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization.
Fan W, Zhu B, Zheng X, Yue S, Lu M, Fan H, Qiao L, Li F, Yuan G, Wu Y, Zou X, Wang H, Xue M, Li J. Fan W, et al. Among authors: zhu b. J Cancer Res Clin Oncol. 2023 May;149(5):1873-1882. doi: 10.1007/s00432-022-04107-w. Epub 2022 Jul 5. J Cancer Res Clin Oncol. 2023. PMID: 35788728
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH).
Peng Z, Fan W, Zhu B, Wang G, Sun J, Xiao C, Huang F, Tang R, Cheng Y, Huang Z, Liang Y, Fan H, Qiao L, Li F, Zhuang W, Peng B, Wang J, Li J, Kuang M. Peng Z, et al. Among authors: zhu b. J Clin Oncol. 2023 Jan 1;41(1):117-127. doi: 10.1200/JCO.22.00392. Epub 2022 Aug 3. J Clin Oncol. 2023. PMID: 35921605 Clinical Trial.
Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational study.
Fan W, Zhu B, Yue S, Zheng X, Yuan G, Yu L, Huang W, Huang S, Wei W, Li F, Huang Z, Tang R, Fan H, Li Z, Qiao L, Huang F, Cheng Y, Zhang Y, Wu Y, Zou X, Xue M, Wang H, Li J. Fan W, et al. Among authors: zhu b. Eur Radiol. 2023 Apr;33(4):2809-2820. doi: 10.1007/s00330-022-09249-6. Epub 2022 Dec 23. Eur Radiol. 2023. PMID: 36562786 Free PMC article.
Anti-PD-L1 antibody enhances curative effect of cryoablation via antibody-dependent cell-mediated cytotoxicity mediating PD-L1highCD11b+ cells elimination in hepatocellular carcinoma.
Tan J, Liu T, Fan W, Wei J, Zhu B, Liu Y, Liu L, Zhang X, Chen S, Lin H, Zhang Y, Li J. Tan J, et al. Among authors: zhu b. Acta Pharm Sin B. 2023 Feb;13(2):632-647. doi: 10.1016/j.apsb.2022.08.006. Epub 2022 Aug 18. Acta Pharm Sin B. 2023. PMID: 36873191 Free PMC article.
10,537 results
You have reached the last available page of results. Please see the User Guide for more information.